T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
As part of the Company’s corporate restructuring plan, Mr. Yaki Baranes will facilitate identifying new…
As part of the Company’s corporate restructuring plan, Mr. Yaki Baranes will facilitate identifying new…
DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…
DOYLESTOWN, Pa., May 30, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…
– Company plans to suspend enrollment in the ongoing milademetan Phase 2 MANTRA-2 basket trial…
– Company plans to suspend enrollment in the ongoing milademetan Phase 2 MANTRA-2 basket trial…
First subject dosed in Phase 1 trial of PYX-106, a fully human immunotherapy antibody candidate…
First subject dosed in Phase 1 trial of PYX-106, a fully human immunotherapy antibody candidate…
BERKELEY HEIGHTS, N.J., May 30, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
BERKELEY HEIGHTS, N.J., May 30, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Results Add to Growing Body of Evidence that Inhibiting PP2A with LB–100 May Be a…
Results Add to Growing Body of Evidence that Inhibiting PP2A with LB–100 May Be a…
TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Morphogenesis, Inc. (“Morphogenesis”),…
TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) — Morphogenesis, Inc. (“Morphogenesis”),…
CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:…
CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq:…
CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology…
CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology…
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…